The Life Sciences sector in the UK has long been known for its resilience and innovation, however over the last few years it has faced an unusual trend – a noticeable slowdown in hiring. Companies in this sector typically thrive on cutting-edge research, drug development, and technological advancements – an industry that has consistently attracted top talent and investment. This unexpected trend has therefore sparked concerns and questions about what is driving this change.
Despite the noticeable hiring slowdown over the past few years, there are encouraging signs that the sector is bouncing back, with vacancies on the rise over the last few months. This positive trend suggests a renewed confidence in the industry, as it adapts to challenges and seizes new opportunities.
1. Economic stability begins to emerge
It is no secret that the UK economy has undergone a period of uncertainty, influenced by both the global economy and domestic challenges. Whilst the aftermath of Brexit continues to cast a shadow over the sector, and the complexities of new trade relationships creating a cautious business environment, recent months have shown signs of stabilisation.
Life sciences companies, which rely heavily on international collaboration, are becoming more optimistic as trade relationships solidify and regulatory clarity improves. This newfound stability is helping to restore confidence and, as a result, hiring has started to pick up.
2. Funding and investment challenges
In the UK, many life sciences companies depend on venture capital, government grants, and partnerships with academic institutions. However, recent economic conditions made it more challenging to secure the funding required. Inflation and rising interest rates have made investors more risk-averse, particularly in sectors like life sciences in which returns are often long-term. There are now encouraging developments, with investors beginning to regain confidence as the outlook improves, and there is a growing interest in life sciences ventures.
The government spending in the UK has also been under pressure, leading to tighter budgets for research grants and public sector funding. This resulted in a slowdown in new hires over the last few years as companies were reserving their funds to sustain current operations. But with the government support gradually returning, and renewed emphasis on innovation and research grants, increased hiring to support expanded operations and new projects is to be expected.
3. Regulatory delays and post-pandemic recovery
The COVID-19 pandemic significantly impacted regulatory bodies, leading to delays in the approval processes for new drugs and medical devices. In the UK, regulatory bodies faced considerable backlogs, worsened by the increased workload from vaccine and treatment approvals during the pandemic. This led to a slow down the progress of clinical trials and the launch of new products.
Life sciences companies were delaying hiring until these issues were resolved, as they cannot afford to expand their teams without clear timelines. Now, there seem to be signs of recovery as regulatory bodies work through these backlogs, accelerating the approval process and enabling companies to advance their pipelines. Companies are becoming more willing to expand their teams, resulting in a noticeable increase in job vacancies.
4. Embracing digitalisation and automation
Digitalisation and automation are transforming the life sciences industry, with companies increasingly investing in technologies that streamline operations and enhance efficiency. The use of AI in drug discovery, automation in laboratories, and digital health technologies are becoming more commonplace.
These advancements offer significant benefits, but they also reduce the need for traditional roles. However, as companies invest in AI, automation, and digital health technologies, they are not only streamlining operations but also creating new roles that require specialised skills. The recent rise in vacancies reflects this shift, with a growing demand for talent skilled in digital and technological fields, demonstrating the sector’s adaptability and forward-thinking approach.
5. Addressing STEM skills shortages
The STEM skills gap refers to the mismatch between the skills in demand from employers and the skills possessed by the current workforce. Despite the increasing demand for STEM skills across various sectors, there is a shortage of individuals qualified to fill these roles. Brexit has also played a key role in this issue, as it has made it more difficult for UK companies to attract talent from the EU, which was previously a significant source of skilled workers.
Efforts are underway to bridge this gap, with initiatives to boost STEM education, attract international talent, and provide upskilling opportunities are gaining traction. As these efforts take effect, companies are increasingly able to find the skilled workers they need, which is contributing to the recent uptick in hiring.
The life sciences sector in the UK is on a path of recovery, with recent months showing a promising increase in job vacancies and a renewed sense of optimism. While challenges remain, the industry’s adaptability and commitment to innovation continue to drive it forward. As we enter a post-Brexit landscape and the global economy begins to restabilise, the hope is that the life sciences sector will continue to build momentum, leading to even more job opportunities and continued growth.
You may also like to read:
STEM skills gap projected to cost the UK £120 billion by 2030
Effective onboarding: Setting your new hires up for success from day one
